- Home
- Publications
- Publication Search
- Publication Details
Title
Antiangiogenic effects of zoledronate on cancer neovasculature
Authors
Keywords
-
Journal
Future Oncology
Volume 7, Issue 11, Pages 1325-1333
Publisher
Future Medicine Ltd
Online
2011-11-01
DOI
10.2217/fon.11.113
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Randomized, Double-Blind Study of Denosumab Versus Zoledronic Acid in the Treatment of Bone Metastases in Patients With Advanced Cancer (Excluding Breast and Prostate Cancer) or Multiple Myeloma
- (2011) David H. Henry et al. JOURNAL OF CLINICAL ONCOLOGY
- Molecular mechanisms and clinical applications of angiogenesis
- (2011) Peter Carmeliet et al. NATURE
- Zoledronic acid induces cell-cycle prolongation in murine lung cancer cells by perturbing cyclin and Ras expression
- (2010) Ying-Ying Li et al. ANTI-CANCER DRUGS
- Metronomic administration of Zoledronic Acid and Taxotere combination in castration resistant prostate cancer patients: Phase I ZANTE trial
- (2010) Gaetano Facchini et al. CANCER BIOLOGY & THERAPY
- PDGFR Signaling Blockade in Marrow Stroma Impairs Lung Cancer Bone Metastasis
- (2010) R. Catena et al. CANCER RESEARCH
- Drug-Induced Vessel Remodeling in Bone Metastases as Assessed by Dynamic Contrast Enhanced Magnetic Resonance Imaging and Vessel Size Imaging: A Longitudinal In vivo Study
- (2010) T. Bauerle et al. CLINICAL CANCER RESEARCH
- Depletion of Tumor-Associated Macrophages Enhances the Effect of Sorafenib in Metastatic Liver Cancer Models by Antimetastatic and Antiangiogenic Effects
- (2010) W. Zhang et al. CLINICAL CANCER RESEARCH
- Preclinical pharmacology of CGP 42′446, a new, potent, heterocyclic bisphosphonate compound
- (2010) Jonathan R. Green et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Enhancing cytotoxic and apoptotic effect in OVCAR-3 and MDAH-2774 cells with all-trans retinoic acid and zoledronic acid: a paradigm of synergistic molecular targeting treatment for ovarian cancer
- (2010) Bulent Karabulut et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Microvascular Endothelial Cell Responses in vitro and in vivo: Modulation by Zoledronic Acid and Paclitaxel?
- (2010) Maria Michailidou et al. JOURNAL OF VASCULAR RESEARCH
- EPCs and pathological angiogenesis: When good cells go bad
- (2010) Sergio Li Calzi et al. MICROVASCULAR RESEARCH
- Accumulation of VEGFR2 in zoledronic acid-treated endothelial cells
- (2010) Basi Molecular Medicine Reports
- Osteonecrosis of the jaw under bisphosphonate and antiangiogenic therapies: cumulative toxicity profile?
- (2009) J. Ayllon et al. ANNALS OF ONCOLOGY
- Zoledronic acid determines S-phase arrest but fails to induce apoptosis in cholangiocarcinoma cells
- (2009) Antonello A. Romani et al. BIOCHEMICAL PHARMACOLOGY
- Phase I Trial of Sunitinib Malate plus Interferon-α for Patients with Metastatic Renal Cell Carcinoma
- (2009) Robert J. Motzer et al. Clinical Genitourinary Cancer
- Bisphosphonates: restrictions for vasculogenesis and angiogenesis: inhibition of cell function of endothelial progenitor cells and mature endothelial cells in vitro
- (2009) Thomas Ziebart et al. Clinical Oral Investigations
- Bortezomib and zoledronic acid on angiogenic and vasculogenic activities of bone marrow macrophages in patients with multiple myeloma
- (2009) Michele Moschetta et al. EUROPEAN JOURNAL OF CANCER
- Utility of Hyperbaric Oxygen in Treatment of Bisphosphonate-Related Osteonecrosis of the Jaws
- (2009) John J. Freiberger JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY
- Bevacizumab-associated osteonecrosis of the jaw
- (2008) S. Greuter et al. ANNALS OF ONCOLOGY
- Bisphosphonate-related osteonecrosis of the jaw is associated with polymorphisms of the cytochrome P450 CYP2C8 in multiple myeloma: a genome-wide single nucleotide polymorphism analysis
- (2008) M. E. Sarasquete et al. BLOOD
- Osteonecrosis of the jaw — Who gets it, and why?
- (2008) Ian R. Reid BONE
- Matrix Metalloproteinase-9 Is Required for Tumor Vasculogenesis but Not for Angiogenesis: Role of Bone Marrow-Derived Myelomonocytic Cells
- (2008) G-One Ahn et al. CANCER CELL
- Anti-Angiogenic Property of Zoledronic Acid by Inhibition of Endothelial Progenitor Cell Differentiation
- (2008) Jun Yamada et al. JOURNAL OF SURGICAL RESEARCH
- Antitumor Effects of Doxorubicin Followed by Zoledronic Acid in a Mouse Model of Breast Cancer
- (2008) P. D. Ottewell et al. JNCI-Journal of the National Cancer Institute
- Effect of zoledronic acid on serum angiogenic factors in patients with bone metastases
- (2008) Faruk Tas et al. MEDICAL ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now